hydroquinone has been researched along with Hyperuricemia in 1 studies
Hyperuricemia: Excessive URIC ACID or urate in blood as defined by its solubility in plasma at 37 degrees C; greater than 0.42mmol per liter (7.0mg/dL) in men or 0.36mmol per liter (6.0mg/dL) in women. This condition is caused by overproduction of uric acid or impaired renal clearance. Hyperuricemia can be acquired, drug-induced or genetically determined (LESCH-NYHAN SYNDROME). It is associated with HYPERTENSION and GOUT.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Benzbromarone (BBR) is effective in the treatment of hyperuricemia, and has been used as an effective drug in Japan for a long time." | 4.95 | Strategic Drug Design to Avoid the Metabolic Activation of Hepatotoxic Drugs. ( Mashino, T; Nakamura, S; Ohe, T; Takahashi, K, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohe, T | 1 |
| Takahashi, K | 1 |
| Nakamura, S | 1 |
| Mashino, T | 1 |
1 review available for hydroquinone and Hyperuricemia
| Article | Year |
|---|---|
Strategic Drug Design to Avoid the Metabolic Activation of Hepatotoxic Drugs.
Topics: Benzbromarone; Catechols; Cell Survival; Chemical and Drug Induced Liver Injury; Cytochrome P-450 En | 2017 |